Formula Growth’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.11M Sell
34,417
-135
-0.4% -$11.4K 1.09% 25
2026
Q1
$2.89M Sell
34,552
-4,848
-12% -$398K 1.3% 21
2025
Q4
$3.61M Sell
39,400
-1,190
-3% -$114K 1.39% 16
2025
Q3
$3.85M Buy
40,590
+11,100
+38% +$1.04M 1.37% 21
2025
Q2
$3.09M Sell
29,490
-510
-2% -$48.3K 1.17% 25
2025
Q1
$2.65M Buy
+30,000
New +$3.08M 1.08% 36
2016
Q2
Sell
-30,200
Closed -$745K 154
2016
Q1
$745K Buy
+30,200
New +$647K 0.18% 136

Other funds holding HQY

Formula Growth's HQY Position: Q2 2026 in Review

Formula Growth reduced its HealthEquity (HQY) stake by 0.39% in Q2 2026, selling an estimated $11.4K and leaving 34,417 shares worth $3.11M. The position accounts for 1.09% of the portfolio, ranked #25.

Formula Growth first reported a position in HQY in Q1 2016 and has held it in 7 quarters since. The position peaked at $3.85M in Q3 2025. 498 funds tracked by Wall St. Rank hold HQY as of Q2 2026.

  • Formula Growth held 34,417 shares of HealthEquity worth $3.11M as of Q2 2026.
  • Formula Growth sold 135 HealthEquity shares in Q2 2026, an estimated $11.4K.
  • HealthEquity made up 1.09% of Formula Growth's portfolio in Q2 2026, its #25 holding.
  • Formula Growth first reported a position in HealthEquity in Q1 2016 and has held it in 7 quarters since.
  • Formula Growth's HealthEquity position peaked at $3.85M in Q3 2025.
  • 498 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.

Based on Formula Growth's 13F filing for Q2 2026, filed 17 Aug 2026.